India Fat-Loss Drug Sales Slow After Early Spike From Generics

India's generic semaglutide market saw rapid initial growth that has since slowed, according to market data. The drugs are used to treat obesity and diabetes. Generic versions entered the Indian market months before the slowdown occurred. Sales velocity declined after the initial spike in demand following product launches.

Next story